13F
中

PDEX PRO-DEX INC

2026Q1 · CUSIP 74265M205 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
57
Δ holders QoQ
+1
Breadth percentile
Top 58%
Whale holders
32
Δ whales
+4
Inst. holding value
$35M
New positions
12
Closed positions
11
Price momentum (1Q)
—
Put / Call
0/0

Breadth history (34 quarters)

2018Q1: Δ+1 · h=15 2018Q2: Δ+0 · h=15 2018Q3: Δ+3 · h=18 2018Q4: Δ+3 · h=21 2019Q1: Δ+1 · h=22 2019Q2: Δ+4 · h=26 2019Q3: Δ+5 · h=31 2019Q4: Δ-5 · h=26 2020Q1: Δ-5 · h=21 2020Q2: Δ+3 · h=24 2020Q3: Δ+2 · h=26 2020Q4: Δ+0 · h=26 2021Q1: Δ+3 · h=29 2021Q2: Δ+1 · h=30 2021Q3: Δ-3 · h=27 2021Q4: Δ-1 · h=26 2022Q1: Δ-3 · h=23 2022Q2: Δ+1 · h=24 2022Q3: Δ-2 · h=22 2022Q4: Δ+1 · h=23 2023Q1: Δ+0 · h=23 2023Q2: Δ+1 · h=24 2023Q3: Δ-2 · h=22 2023Q4: Δ+2 · h=24 2024Q1: Δ+1 · h=25 2024Q2: Δ+1 · h=26 2024Q3: Δ-1 · h=25 2024Q4: Δ+18 · h=43 2025Q1: Δ+1 · h=44 2025Q2: Δ+9 · h=53 2025Q3: Δ+3 · h=56 2025Q4: Δ+0 · h=56 2026Q1: Δ+1 · h=57 2018Q1: holders=15 2018Q2: holders=15 2018Q3: holders=18 2018Q4: holders=21 2019Q1: holders=22 2019Q2: holders=26 2019Q3: holders=31 2019Q4: holders=26 2020Q1: holders=21 2020Q2: holders=24 2020Q3: holders=26 2020Q4: holders=26 2021Q1: holders=29 2021Q2: holders=30 2021Q3: holders=27 2021Q4: holders=26 2022Q1: holders=23 2022Q2: holders=24 2022Q3: holders=22 2022Q4: holders=23 2023Q1: holders=23 2023Q2: holders=24 2023Q3: holders=22 2023Q4: holders=24 2024Q1: holders=25 2024Q2: holders=26 2024Q3: holders=25 2024Q4: holders=43 2025Q1: holders=44 2025Q2: holders=53 2025Q3: holders=56 2025Q4: holders=56 2026Q1: holders=57 -18 -9 +0 +9 +18 133760 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 0 lit events

No lit events in history

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
16.5
EPS (TTM)
$3.59
EPS YoY
+29.1%
Revenue (TTM)
$0.1B
Revenue YoY
+16.4%
Quarterly Revenue & EPS (4Y)
2022-06-30: $13M 2022-09-30: $11M 2022-12-31: $11M 2023-03-31: $13M 2023-06-30: $11M 2023-09-30: $12M 2023-12-31: $13M 2024-03-31: $14M 2024-06-30: $15M 2024-09-30: $15M 2024-12-31: $17M 2025-03-31: $17M 2025-06-30: $17M 2025-09-30: $19M 2025-12-31: $19M 2026-03-31: $20M 2023-09-30: EPS -0.17 2023-12-31: EPS 0.14 2024-03-31: EPS 0.19 2024-06-30: EPS 0.44 2024-09-30: EPS 0.75 2024-12-31: EPS 0.61 2025-03-31: EPS 0.98 2025-06-30: EPS 0.33 2025-09-30: EPS 1.40 2025-12-31: EPS 0.66 2026-03-31: EPS 1.20 0M 10M 20M $M -0.19 0.68 1.54 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 17 2024-06-30: PE 32.92024-09-30: PE 30.32024-12-31: PE 17.82025-03-31: PE 15.52025-06-30: PE 162025-09-30: PE 9.72025-12-31: PE 11.72026-03-31: PE 16.5 9 22 35 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)